Tekmira Pharmaceuticals Corporation (TKMR)
Add to Watchlists Create an Alert
4.73
-0.09 -1.87%
NASDAQ
May 22, 5:00PM
BATS Real time
Currency in USD
Tekmira Pharmaceuticals Corporation Net Interest Income Quarterly:
0.0594M for Dec. 31, 2012Tekmira Pharmaceuticals Corporation Historical Net Interest Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.0594M |
| Sept. 30, 2012 | 0.0261M |
| June 30, 2012 | 0.0284M |
| March 31, 2012 | 0.0243M |
| Dec. 31, 2011 | 0.044M |
| Sept. 30, 2011 | 0.0171M |
| June 30, 2011 | 0.0295M |
| March 31, 2011 | 0.0341M |
| Dec. 31, 2010 | 0.0281M |
| Sept. 30, 2010 | 0.031M |
| June 30, 2010 | 0.0242M |
| March 31, 2010 | 0.021M |
About Interest Income
Revenues from interest-bearing assets. A typical example would be interest earned by a bank on personal or commercial loans.
Learn More
TKMR Net Interest Income Quarterly Benchmarks
| Companies | |
|---|---|
| Alnylam Pharmaceuticals | 0.224M |
| DelMar Pharmaceuticals | |
| Arqule | 0.144M |
TKMR Net Interest Income Quarterly Rankings
| Overall |
85th percentile 1135 of 8005 |
| Sector |
89th percentile 69 of 686 in Healthcare |
| Industry |
87th percentile 30 of 248 in Biotechnology |
TKMR Net Interest Income Quarterly Range, Past 5 Years
| Minimum | 0.0171M | Sep 2011 |
| Maximum | 0.2450M | Sep 2008 |
| Average | 0.0598M |
TKMR News
Tekmira Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 14
Seeking Alpha May 14